Global and United States Argatroban Market Research by Company, Type & Application 2013-2025
SUMMARY
Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.
Market Segment as follows:
By Type
Section 1:
Product definition, type and application, global and United States market overview;
Section 2:
Global and United States Market competition by company;
Section 3:
Global and United States sales revenue, volume and price by type;
Section 4:
Global and United States sales revenue, volume and price by application;
Section 5:
United States export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.
Market Segment as follows:
By Type
- Argatroban Powder
- Argatroban Injection
- Heparin-induced thrombocytopenia (HIT)
- Percutaneous Coronary Intervention
- Cerebral arterial thrombosis
- Pfizer
- SANDOZ
- GlaxoSmithKline
- fresenius-kabi
- Eagle Pharmaceuticals
- Mitsubishi Tanabe Pharma
- Teva Pharmaceutical Industries
- WEST-WARD
Section 1:
Product definition, type and application, global and United States market overview;
Section 2:
Global and United States Market competition by company;
Section 3:
Global and United States sales revenue, volume and price by type;
Section 4:
Global and United States sales revenue, volume and price by application;
Section 5:
United States export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
1 MARKET OVERVIEW
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 Argatroban Powder
1.1.2.2 Argatroban Injection
1.1.3 Market by Application
1.1.3.1 Heparin-induced thrombocytopenia (HIT)
1.1.3.2 Percutaneous Coronary Intervention
1.1.3.3 Cerebral arterial thrombosis
1.2 Global and Regional Market Size
1.2.1 Global Overview
1.2.2 United States Overview
2 GLOBAL AND REGIONAL MARKET BY COMPANY
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 United States
2.2.1 United States Sales by Company
2.2.2 United States Price by Company
3 GLOBAL AND REGIONAL MARKET BY TYPE
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 United States
3.2.1 United States Sales by Type
3.2.2 United States Price by Type
4 GLOBAL AND REGIONAL MARKET BY APPLICATION
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 United States
4.2.1 United States Sales by Application
4.2.2 United States Price by Application
5 REGIONAL TRADE
5.1 Export
5.2 Import
6 KEY MANUFACTURERS
6.1 Pfizer
6.1.2 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 SANDOZ
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 GlaxoSmithKline
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 fresenius-kabi
6.4.1 Company Information
6.4.2 Product Specifications
6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 Eagle Pharmaceuticals
6.5.1 Company Information
6.5.2 Product Specifications
6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Mitsubishi Tanabe Pharma
6.6.1 Company Information
6.6.2 Product Specifications
6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Teva Pharmaceutical Industries
6.7.1 Company Information
6.7.2 Product Specifications
6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 WEST-WARD
6.8.1 Company Information
6.8.2 Product Specifications
6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
7 INDUSTRY UPSTREAM
7.1 Industry Chain
7.2 Raw Materials
8 MARKET ENVIRONMENT
8.1 SWOT
8.2 Porter's Five Forces
9 CONCLUSION
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 Argatroban Powder
1.1.2.2 Argatroban Injection
1.1.3 Market by Application
1.1.3.1 Heparin-induced thrombocytopenia (HIT)
1.1.3.2 Percutaneous Coronary Intervention
1.1.3.3 Cerebral arterial thrombosis
1.2 Global and Regional Market Size
1.2.1 Global Overview
1.2.2 United States Overview
2 GLOBAL AND REGIONAL MARKET BY COMPANY
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 United States
2.2.1 United States Sales by Company
2.2.2 United States Price by Company
3 GLOBAL AND REGIONAL MARKET BY TYPE
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 United States
3.2.1 United States Sales by Type
3.2.2 United States Price by Type
4 GLOBAL AND REGIONAL MARKET BY APPLICATION
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 United States
4.2.1 United States Sales by Application
4.2.2 United States Price by Application
5 REGIONAL TRADE
5.1 Export
5.2 Import
6 KEY MANUFACTURERS
6.1 Pfizer
6.1.2 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 SANDOZ
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 GlaxoSmithKline
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 fresenius-kabi
6.4.1 Company Information
6.4.2 Product Specifications
6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 Eagle Pharmaceuticals
6.5.1 Company Information
6.5.2 Product Specifications
6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Mitsubishi Tanabe Pharma
6.6.1 Company Information
6.6.2 Product Specifications
6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Teva Pharmaceutical Industries
6.7.1 Company Information
6.7.2 Product Specifications
6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 WEST-WARD
6.8.1 Company Information
6.8.2 Product Specifications
6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
7 INDUSTRY UPSTREAM
7.1 Industry Chain
7.2 Raw Materials
8 MARKET ENVIRONMENT
8.1 SWOT
8.2 Porter's Five Forces
9 CONCLUSION
LIST OF TABLES
Table Global Market Sales Revenue by Company 2013-2017
Table Global Market Sales Revenue Share by Company 2013-2017
Table Global Market Sales Volume by Company 2013-2017
Table Global Market Sales Volume Share by Company 2013-2017
Table Global Price by Company 2013-2017
Table United States Market Sales Revenue by Company 2013-2017
Table United States Market Sales Revenue Share by Company 2013-2017
Table United States Market Sales Volume by Company 2013-2017
Table United States Market Sales Volume Share by Company 2013-2017
Table United States Price by Company 2013-2017
Table Global Market Sales Revenue by Type 2013-2017
Table Global Market Sales Revenue Share by Type 2013-2017
Table Global Market Sales Volume by Type 2013-2017
Table Global Market Sales Volume Share by Type 2013-2017
Table Global Price by Type 2013-2017
Table United States Market Sales Revenue by Type 2013-2017
Table United States Market Sales Revenue Share by Type 2013-2017
Table United States Market Sales Volume by Type 2013-2017
Table United States Market Sales Volume Share by Type 2013-2017
Table United States Price by Type 2013-2017
Table Global Market Sales Revenue by Application 2013-2017
Table Global Market Sales Revenue Share by Application 2013-2017
Table Global Market Sales Volume by Application 2013-2017
Table Global Market Sales Volume Share by Application 2013-2017
Table Global Price by Application 2013-2017
Table United States Market Sales Revenue by Application 2013-2017
Table United States Market Sales Revenue Share by Application 2013-2017
Table United States Market Sales Volume by Application 2013-2017
Table United States Market Sales Volume Share by Application 2013-2017
Table United States Price by Application 2013-2017
Table United States Export 2013-2017 (Million USD)
Table United States Export 2013-2017 (Volume)
Table United States Import 2013-2017 (Million USD)
Table United States Import 2013-2017 (Volume)
Table Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Table Sales Revenue, Volume, Price, Cost and Margin of SANDOZ
Table Sales Revenue, Volume, Price, Cost and Margin of GlaxoSmithKline
Table Sales Revenue, Volume, Price, Cost and Margin of fresenius-kabi
Table Sales Revenue, Volume, Price, Cost and Margin of Eagle Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Mitsubishi Tanabe Pharma
Table Sales Revenue, Volume, Price, Cost and Margin of Teva Pharmaceutical Industries
Table Sales Revenue, Volume, Price, Cost and Margin of WEST-WARD
Table Global Market Sales Revenue by Company 2013-2017
Table Global Market Sales Revenue Share by Company 2013-2017
Table Global Market Sales Volume by Company 2013-2017
Table Global Market Sales Volume Share by Company 2013-2017
Table Global Price by Company 2013-2017
Table United States Market Sales Revenue by Company 2013-2017
Table United States Market Sales Revenue Share by Company 2013-2017
Table United States Market Sales Volume by Company 2013-2017
Table United States Market Sales Volume Share by Company 2013-2017
Table United States Price by Company 2013-2017
Table Global Market Sales Revenue by Type 2013-2017
Table Global Market Sales Revenue Share by Type 2013-2017
Table Global Market Sales Volume by Type 2013-2017
Table Global Market Sales Volume Share by Type 2013-2017
Table Global Price by Type 2013-2017
Table United States Market Sales Revenue by Type 2013-2017
Table United States Market Sales Revenue Share by Type 2013-2017
Table United States Market Sales Volume by Type 2013-2017
Table United States Market Sales Volume Share by Type 2013-2017
Table United States Price by Type 2013-2017
Table Global Market Sales Revenue by Application 2013-2017
Table Global Market Sales Revenue Share by Application 2013-2017
Table Global Market Sales Volume by Application 2013-2017
Table Global Market Sales Volume Share by Application 2013-2017
Table Global Price by Application 2013-2017
Table United States Market Sales Revenue by Application 2013-2017
Table United States Market Sales Revenue Share by Application 2013-2017
Table United States Market Sales Volume by Application 2013-2017
Table United States Market Sales Volume Share by Application 2013-2017
Table United States Price by Application 2013-2017
Table United States Export 2013-2017 (Million USD)
Table United States Export 2013-2017 (Volume)
Table United States Import 2013-2017 (Million USD)
Table United States Import 2013-2017 (Volume)
Table Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Table Sales Revenue, Volume, Price, Cost and Margin of SANDOZ
Table Sales Revenue, Volume, Price, Cost and Margin of GlaxoSmithKline
Table Sales Revenue, Volume, Price, Cost and Margin of fresenius-kabi
Table Sales Revenue, Volume, Price, Cost and Margin of Eagle Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Mitsubishi Tanabe Pharma
Table Sales Revenue, Volume, Price, Cost and Margin of Teva Pharmaceutical Industries
Table Sales Revenue, Volume, Price, Cost and Margin of WEST-WARD
LIST OF FIGURES
Figure Argatroban Powder Market Size and CAGR 2013-2017 (Million USD)
Figure Argatroban Powder Market Size and CAGR 2013-2017 (Volume)
Figure Argatroban Powder Market Forecast and CAGR 2018-2025 (Million USD)
Figure Argatroban Powder Market Forecast and CAGR 2018-2025 (Volume)
Figure Argatroban Injection Market Size and CAGR 2013-2017 (Million USD)
Figure Argatroban Injection Market Size and CAGR 2013-2017 (Volume)
Figure Argatroban Injection Market Forecast and CAGR 2018-2025 (Million USD)
Figure Argatroban Injection Market Forecast and CAGR 2018-2025 (Volume)
Figure Heparin-induced thrombocytopenia (HIT) Market Size and CAGR 2013-2017 (Million USD)
Figure Heparin-induced thrombocytopenia (HIT) Market Size and CAGR 2013-2017 (Volume)
Figure Heparin-induced thrombocytopenia (HIT) Market Forecast and CAGR 2018-2025 (Million USD)
Figure Heparin-induced thrombocytopenia (HIT) Market Forecast and CAGR 2018-2025 (Volume)
Figure Percutaneous Coronary Intervention Market Size and CAGR 2013-2017 (Million USD)
Figure Percutaneous Coronary Intervention Market Size and CAGR 2013-2017 (Volume)
Figure Percutaneous Coronary Intervention Market Forecast and CAGR 2018-2025 (Million USD)
Figure Percutaneous Coronary Intervention Market Forecast and CAGR 2018-2025 (Volume)
Figure Cerebral arterial thrombosis Market Size and CAGR 2013-2017 (Million USD)
Figure Cerebral arterial thrombosis Market Size and CAGR 2013-2017 (Volume)
Figure Cerebral arterial thrombosis Market Forecast and CAGR 2018-2025 (Million USD)
Figure Cerebral arterial thrombosis Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Argatroban Market Size and CAGR 2013-2017 (Million USD)
Figure Global Argatroban Market Size and CAGR 2013-2017 (Volume)
Figure Global Argatroban Market Forecast and CAGR 2018-2025 (Million USD)
Figure Global Argatroban Market Forecast and CAGR 2018-2025 (Volume)
Figure United States Argatroban Market Size and CAGR 2013-2017 (Million USD)
Figure United States Argatroban Market Size and CAGR 2013-2017 (Volume)
Figure United States Argatroban Market Forecast and CAGR 2018-2025 (Million USD)
Figure United States Argatroban Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure United States Market Sales Revenue Share by Company in 2017
Figure United States Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure United States Market Sales Revenue Share by Type in 2017
Figure United States Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure United States Market Sales Revenue Share by Application in 2017
Figure United States Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Argatroban SWOT List
Figure Healthcare & Medical Porter's Five Forces
Figure Argatroban Powder Market Size and CAGR 2013-2017 (Million USD)
Figure Argatroban Powder Market Size and CAGR 2013-2017 (Volume)
Figure Argatroban Powder Market Forecast and CAGR 2018-2025 (Million USD)
Figure Argatroban Powder Market Forecast and CAGR 2018-2025 (Volume)
Figure Argatroban Injection Market Size and CAGR 2013-2017 (Million USD)
Figure Argatroban Injection Market Size and CAGR 2013-2017 (Volume)
Figure Argatroban Injection Market Forecast and CAGR 2018-2025 (Million USD)
Figure Argatroban Injection Market Forecast and CAGR 2018-2025 (Volume)
Figure Heparin-induced thrombocytopenia (HIT) Market Size and CAGR 2013-2017 (Million USD)
Figure Heparin-induced thrombocytopenia (HIT) Market Size and CAGR 2013-2017 (Volume)
Figure Heparin-induced thrombocytopenia (HIT) Market Forecast and CAGR 2018-2025 (Million USD)
Figure Heparin-induced thrombocytopenia (HIT) Market Forecast and CAGR 2018-2025 (Volume)
Figure Percutaneous Coronary Intervention Market Size and CAGR 2013-2017 (Million USD)
Figure Percutaneous Coronary Intervention Market Size and CAGR 2013-2017 (Volume)
Figure Percutaneous Coronary Intervention Market Forecast and CAGR 2018-2025 (Million USD)
Figure Percutaneous Coronary Intervention Market Forecast and CAGR 2018-2025 (Volume)
Figure Cerebral arterial thrombosis Market Size and CAGR 2013-2017 (Million USD)
Figure Cerebral arterial thrombosis Market Size and CAGR 2013-2017 (Volume)
Figure Cerebral arterial thrombosis Market Forecast and CAGR 2018-2025 (Million USD)
Figure Cerebral arterial thrombosis Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Argatroban Market Size and CAGR 2013-2017 (Million USD)
Figure Global Argatroban Market Size and CAGR 2013-2017 (Volume)
Figure Global Argatroban Market Forecast and CAGR 2018-2025 (Million USD)
Figure Global Argatroban Market Forecast and CAGR 2018-2025 (Volume)
Figure United States Argatroban Market Size and CAGR 2013-2017 (Million USD)
Figure United States Argatroban Market Size and CAGR 2013-2017 (Volume)
Figure United States Argatroban Market Forecast and CAGR 2018-2025 (Million USD)
Figure United States Argatroban Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure United States Market Sales Revenue Share by Company in 2017
Figure United States Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure United States Market Sales Revenue Share by Type in 2017
Figure United States Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure United States Market Sales Revenue Share by Application in 2017
Figure United States Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Argatroban SWOT List
Figure Healthcare & Medical Porter's Five Forces
